Susan Coles
Chief Legal Officer
Susan is an experienced legal executive with more than 25 years of expertise in international collaborations, corporate governance, licensing, and commercial transactions, particularly in the life sciences sector.
She previously served as General Counsel of Vivet Therapeutics from 2017 to 2025 and of Stallergenes from 2014 to 2017. Susan also previously served as General Counsel of Inventiva from 2012 to 2014 and again from 2019 to 2021. Earlier in her career, she was Senior Counsel responsible for Licensing and Acquisitions at Laboratoires Fournier and subsequently Solvay Pharmaceuticals following its acquisition of Fournier.
Susan has served on the Supervisory Board of TME Pharma since 2021. She holds a B.A. in Psychology from the University of British Columbia and an LL.B. from the University of Toronto. She is an attorney of the Bar of Ontario and the New York Bar.